Watch Demo

Mexico Anti-Infective Industry Outlook 2024 - 2028

See how Mexico Anti-Infective performed compared to key markets such as Italy, Spain and Croatia.

Key Market Indicators

The sales of antiinfective medicines in Mexico are projected to reach approximately $1.33 billion by 2028, up from around $1.18 billion in 2023. This marks an average annual growth rate of 1.9%. Despite this growth, the Mexican market has experienced a slight decline of 0.4% per year since 2005. In 2023, Mexico ranked fifth in the global market for antiinfective medicine sales, with Australia leading the ranking at $1.18 billion. Spain, Croatia, and Australia occupied the second, third, and fourth positions, respectively. In terms of antibiotics imports, Mexico is expected to reach roughly $198 million by 2028, up from about $189 million in 2023, growing at an annual compound rate of 0.7%. Since 1995, the demand for antibiotics in Mexico has remained relatively stable, showing no significant year-on-year change. On the export front, Mexican antibiotics saw a slight decline, with exports totaling approximately $2.91 million in 2018, down from around $2.92 million in 2017, reflecting a 0.4% decrease. The export supply has seen a more dramatic drop, decreasing by 50.4% annually since 1995.

Marketing Banner

Mexico Anti-Infective Market Data and Forecasts

How much will Mexico Anti-Infective Market grow to 2028?

Forecast: Import of Antibiotics to Mexico
Forecast: Import of Erythromycin to Mexico
Forecast: Import of Penicillins to Mexico
Forecast: Import of Chloramphenicol to Mexico
More in Anti-Infective Industry for 2028